|
KIAA0895 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.178800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.997200E-01 |
| Normal-vs-Stage2 |
9.230600E-01 |
| Normal-vs-Stage3 |
1.015860E-02 |
| Normal-vs-Stage4 |
7.799200E-01 |
| Stage1-vs-Stage2 |
7.539400E-01 |
| Stage1-vs-Stage3 |
4.827800E-02 |
| Stage1-vs-Stage4 |
8.693000E-01 |
| Stage2-vs-Stage3 |
1.778000E-01 |
| Stage2-vs-Stage4 |
9.380600E-01 |
| Stage3-vs-Stage4 |
1.384180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.545200E-01 |
| Normal-vs-AfricanAmerican |
7.795000E-01 |
| Normal-vs-Asian |
7.098200E-01 |
| Caucasian-vs-AfricanAmerican |
5.752800E-01 |
| Caucasian-vs-Asian |
9.682800E-01 |
| AfricanAmerican-vs-Asian |
8.249200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.525600E-01 |
| Normal-vs-Female |
4.370400E-01 |
| Male-vs-Female |
9.547400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.548100E-02 |
| Normal-vs-Extreme_Weight |
1.016610E-01 |
| Normal-vs-Obese |
5.395800E-01 |
| Normal-vs-Extreme_Obese |
7.085200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.696600E-01 |
| Normal_Weight-vs-Obese |
2.477000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.020000E-01 |
| Extreme_Weight-vs-Obese |
3.657600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.512000E-01 |
| Obese-vs-Extreme_Obese |
8.938800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.497200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.620800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.717800E-02 |
| Normal-vs-Age(81-100Yrs) |
4.948000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.629800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.919500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.560600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.842800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.061400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.395200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.003980E-01 |
| Normal-VS-Type2 PRCC |
3.68780000004065E-06 |
| Normal-VS-KIRP CIMP |
3.580000E-02 |
| Normal-VS-Unclassified PRCC |
9.562600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.6039003458701E-10 |
| Type1 PRCC-VS-KIRP CIMP |
3.720300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.681800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.685600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.338260E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.602610E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.503600E-03 |
| Normal-vs-N1 |
1.514810E-01 |
| Normal-vs-N2 |
1.127360E-01 |
| N0-vs-N1 |
5.086600E-01 |
| N0-vs-N2 |
8.366600E-01 |
| N1-vs-N2 |
3.646200E-01 |
|
|
